Stock Updates

Today’s Top Gainers in the Market Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) from Healthcare

Today’s top gainers include the company Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) which is in the industry Biotechnology, gaining 0.42% today. In the last week its performance is -2.11%, and 1.23% for the past quarter. Currently, Vertex Pharmaceuticals Incorporated, VRTX has a target price of 108.95, so today’s gain of 0.42% is a significant step towards its target price. The GAP today is therefore 1.37%.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), has a market cap of 22071, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 97.00%.

At the current price of 88.15, it has a dividend yield of *TBA, and its target price is 108.95. This is with a profit margin of -30.90%, and total debt/equity of 0.86. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has a P/E of *TBA, as well as a forward P/E of 26.94.

With a current EPS of -1.65, and a forecasted EPS growth for next year at 198.81%,Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has had a EPS growth for the past five years at 9.30%. For the next five years EPS growth is projected to be 51.20%.

Performance for the year is -33.98%. Since its IPO date on 7/24/1991, the total performance to date is -29.95%.

Volume today for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), is 990289, while its average volume is 1743.65. Whilst the total gain today was 0.42%, it did have a day high of -8.64%.

Volatility for this week has been at 2.25%, and 3.30% for the month. The 52-week low for Vertex Pharmaceuticals Incorporated, VRTX has been 16.14%, while the 52-week-high has reached -38.55%.

Looking at its return of investments, which is -28.20%, and its return on assets is -16.30%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has an operating margin of -23.90%. With a sales growth of 187.40% quarter over quarter. Bearing in mind that Vertex Pharmaceuticals Incorporated, VRTX is in the sector Healthcare, its long-term debt/equity is 0.69, and has a current ratio of 2.5 and 2.4 for quick ratio.

So what is the value of Vertex Pharmaceuticals Incorporated? Well its PEG is *TBA, and the P/S is 17.08, along with a P/B of 22.43. Meanwhile it has a p/cash of 21.52.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment